2025-04-012026-03-312026-03-31false14492639WEST UROLOGY LIMITED2026-06-26falseiso4217:GBPxbrli:pure144926392025-03-31144926392026-03-31144926392025-04-012026-03-31144926392024-03-31144926392025-03-31144926392024-04-012025-03-3114492639bus:SmallEntities2025-04-012026-03-3114492639bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3114492639bus:FullAccounts2025-04-012026-03-3114492639bus:PrivateLimitedCompanyLtd2025-04-012026-03-3114492639core:WithinOneYear2026-03-3114492639core:AfterOneYear2026-03-3114492639core:WithinOneYear2025-03-3114492639core:AfterOneYear2025-03-3114492639core:ShareCapital2026-03-3114492639core:SharePremium2026-03-3114492639core:RevaluationReserve2026-03-3114492639core:OtherReservesSubtotal2026-03-3114492639core:RetainedEarningsAccumulatedLosses2026-03-3114492639core:ShareCapital2025-03-3114492639core:SharePremium2025-03-3114492639core:RevaluationReserve2025-03-3114492639core:OtherReservesSubtotal2025-03-3114492639core:RetainedEarningsAccumulatedLosses2025-03-3114492639core:LandBuildings2026-03-3114492639core:PlantMachinery2026-03-3114492639core:Vehicles2026-03-3114492639core:FurnitureFittings2026-03-3114492639core:OfficeEquipment2026-03-3114492639core:NetGoodwill2026-03-3114492639core:IntangibleAssetsOtherThanGoodwill2026-03-3114492639core:ListedExchangeTraded2026-03-3114492639core:UnlistedNon-exchangeTraded2026-03-3114492639core:LandBuildings2025-03-3114492639core:PlantMachinery2025-03-3114492639core:Vehicles2025-03-3114492639core:FurnitureFittings2025-03-3114492639core:OfficeEquipment2025-03-3114492639core:NetGoodwill2025-03-3114492639core:IntangibleAssetsOtherThanGoodwill2025-03-3114492639core:ListedExchangeTraded2025-03-3114492639core:UnlistedNon-exchangeTraded2025-03-3114492639core:LandBuildings2025-04-012026-03-3114492639core:PlantMachinery2025-04-012026-03-3114492639core:Vehicles2025-04-012026-03-3114492639core:FurnitureFittings2025-04-012026-03-3114492639core:OfficeEquipment2025-04-012026-03-3114492639core:NetGoodwill2025-04-012026-03-3114492639core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3114492639core:ListedExchangeTraded2025-04-012026-03-3114492639core:UnlistedNon-exchangeTraded2025-04-012026-03-3114492639core:MoreThanFiveYears2025-04-012026-03-3114492639core:Non-currentFinancialInstruments2026-03-3114492639core:Non-currentFinancialInstruments2025-03-3114492639dpl:CostSales2025-04-012026-03-3114492639dpl:DistributionCosts2025-04-012026-03-3114492639core:LandBuildings2025-04-012026-03-3114492639core:PlantMachinery2025-04-012026-03-3114492639core:Vehicles2025-04-012026-03-3114492639core:FurnitureFittings2025-04-012026-03-3114492639core:OfficeEquipment2025-04-012026-03-3114492639dpl:AdministrativeExpenses2025-04-012026-03-3114492639core:NetGoodwill2025-04-012026-03-3114492639core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3114492639dpl:GroupUndertakings2025-04-012026-03-3114492639dpl:ParticipatingInterests2025-04-012026-03-3114492639dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3114492639core:ListedExchangeTraded2025-04-012026-03-3114492639dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3114492639core:UnlistedNon-exchangeTraded2025-04-012026-03-3114492639dpl:CostSales2024-04-012025-03-3114492639dpl:DistributionCosts2024-04-012025-03-3114492639core:LandBuildings2024-04-012025-03-3114492639core:PlantMachinery2024-04-012025-03-3114492639core:Vehicles2024-04-012025-03-3114492639core:FurnitureFittings2024-04-012025-03-3114492639core:OfficeEquipment2024-04-012025-03-3114492639dpl:AdministrativeExpenses2024-04-012025-03-3114492639core:NetGoodwill2024-04-012025-03-3114492639core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3114492639dpl:GroupUndertakings2024-04-012025-03-3114492639dpl:ParticipatingInterests2024-04-012025-03-3114492639dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3114492639core:ListedExchangeTraded2024-04-012025-03-3114492639dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3114492639core:UnlistedNon-exchangeTraded2024-04-012025-03-3114492639core:NetGoodwill2026-03-3114492639core:IntangibleAssetsOtherThanGoodwill2026-03-3114492639core:LandBuildings2026-03-3114492639core:PlantMachinery2026-03-3114492639core:Vehicles2026-03-3114492639core:FurnitureFittings2026-03-3114492639core:OfficeEquipment2026-03-3114492639core:AfterOneYear2026-03-3114492639core:WithinOneYear2026-03-3114492639core:ListedExchangeTraded2026-03-3114492639core:UnlistedNon-exchangeTraded2026-03-3114492639core:ShareCapital2026-03-3114492639core:SharePremium2026-03-3114492639core:RevaluationReserve2026-03-3114492639core:OtherReservesSubtotal2026-03-3114492639core:RetainedEarningsAccumulatedLosses2026-03-3114492639core:NetGoodwill2025-03-3114492639core:IntangibleAssetsOtherThanGoodwill2025-03-3114492639core:LandBuildings2025-03-3114492639core:PlantMachinery2025-03-3114492639core:Vehicles2025-03-3114492639core:FurnitureFittings2025-03-3114492639core:OfficeEquipment2025-03-3114492639core:AfterOneYear2025-03-3114492639core:WithinOneYear2025-03-3114492639core:ListedExchangeTraded2025-03-3114492639core:UnlistedNon-exchangeTraded2025-03-3114492639core:ShareCapital2025-03-3114492639core:SharePremium2025-03-3114492639core:RevaluationReserve2025-03-3114492639core:OtherReservesSubtotal2025-03-3114492639core:RetainedEarningsAccumulatedLosses2025-03-3114492639core:NetGoodwill2024-03-3114492639core:IntangibleAssetsOtherThanGoodwill2024-03-3114492639core:LandBuildings2024-03-3114492639core:PlantMachinery2024-03-3114492639core:Vehicles2024-03-3114492639core:FurnitureFittings2024-03-3114492639core:OfficeEquipment2024-03-3114492639core:AfterOneYear2024-03-3114492639core:WithinOneYear2024-03-3114492639core:ListedExchangeTraded2024-03-3114492639core:UnlistedNon-exchangeTraded2024-03-3114492639core:ShareCapital2024-03-3114492639core:SharePremium2024-03-3114492639core:RevaluationReserve2024-03-3114492639core:OtherReservesSubtotal2024-03-3114492639core:RetainedEarningsAccumulatedLosses2024-03-3114492639core:AfterOneYear2025-04-012026-03-3114492639core:WithinOneYear2025-04-012026-03-3114492639core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3114492639core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3114492639core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3114492639core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3114492639core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3114492639core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3114492639core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3114492639core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3114492639core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3114492639core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3114492639core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3114492639core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3114492639core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3114492639core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3114492639core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3114492639core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3114492639core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3114492639core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3114492639core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3114492639core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3114492639core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3114492639core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3114492639core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3114492639core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3114492639core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3114492639core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3114492639core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3114492639bus:Director12025-04-012026-03-31

WEST UROLOGY LIMITED

Registered Number
14492639
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

WEST UROLOGY LIMITED
Company Information
for the year from 1 April 2025 to 31 March 2026

Director

STRUSS, Werner Jan, Dr

Registered Address

1st Floor, Buckley House 31a The Hundred
Romsey
SO51 8GD

Registered Number

14492639 (England and Wales)
WEST UROLOGY LIMITED
Balance Sheet as at
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Investments330,000-
30,000-
Current assets
Debtors43,6201,230
Cash at bank and on hand6,93721,243
10,55722,473
Creditors amounts falling due within one year5(11,404)(5,738)
Net current assets (liabilities)(847)16,735
Total assets less current liabilities29,15316,735
Net assets29,15316,735
Capital and reserves
Called up share capital120120
Profit and loss account29,03316,615
Shareholders' funds29,15316,735
The financial statements were approved and authorised for issue by the Director on 26 June 2026, and are signed on its behalf by:
STRUSS, Werner Jan, Dr
Director
Registered Company No. 14492639
WEST UROLOGY LIMITED
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
2.Average number of employees

20262025
Average number of employees during the year11
3.Fixed asset investments
During the year, the company has made £30,000 contribution towards Hampshire Clinicians LLP, - this comprises of £3,000 as capital contribution& £27,000 in form of loan notes.

Other investments1

Other loans2

Total

£££
Cost or valuation
Additions3,00027,00030,000
At 31 March 263,00027,00030,000
Net book value
At 31 March 263,00027,00030,000
At 31 March 25---

Notes

1Other investments other than loans
2Other loans classified under investments
4.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables2,3601,230
Other debtors1,260-
Total3,6201,230
5.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables6,792-
Taxation and social security3,2924,044
Other creditors-584
Accrued liabilities and deferred income1,3201,110
Total11,4045,738